about
A randomised controlled trial of triple antiplatelet therapy (aspirin, clopidogrel and dipyridamole) in the secondary prevention of stroke: safety, tolerability and feasibilityColony stimulating factors (including erythropoietin, granulocyte colony stimulating factor and analogues) for strokeColony stimulating factors (including erythropoietin, granulocyte colony stimulating factor and analogues) for strokeStroke severity, early recovery and outcome are each related with clinical classification of stroke: data from the 'Tinzaparin in Acute Ischaemic Stroke Trial' (TAIST)Early recovery and functional outcome are related with causal stroke subtype: data from the tinzaparin in acute ischemic stroke trialRelationship between outcome and baseline blood pressure and other haemodynamic measures in acute ischaemic stroke: data from the TAIST trialSex differences in quality of life in stroke survivors: data from the Tinzaparin in Acute Ischaemic Stroke Trial (TAIST)Compression stockings and the prevention of symptomatic venous thromboembolism: data from the Tinzaparin in Acute Ischemic Stroke TrialWho should have a pre–discharge home assessment visit after a stroke? A qualitative study of occupational therapists' viewsTherapeutic Potential of Transdermal Glyceryl Trinitrate in the Management of Acute Stroke.The cog-4 subset of the national institutes of health stroke scale as a measure of cognition: relationship with baseline factors and functional outcome after stroke using data from the virtual international stroke trials archiveVery low quality of life after acute stroke: data from the Efficacy of Nitric Oxide in Stroke trial.Relationship between poststroke cognition, baseline factors, and functional outcome: data from "efficacy of nitric oxide in stroke" trial.Performance characteristics of methods for quantifying spontaneous intracerebral haemorrhage: data from the Efficacy of Nitric Oxide in Stroke (ENOS) trial.Effect of nitric oxide donors on blood pressure and pulse pressure in acute and subacute stroke.Remote Assessment of Platelet Function in Patients with Acute Stroke or Transient Ischaemic AttackQuality of life after ischemic stroke varies in western countries: data from the tinzaparin in Acute Ischaemic Stroke Trial (TAIST).Balance of symptomatic pulmonary embolism and symptomatic intracerebral hemorrhage with low-dose anticoagulation in recent ischemic stroke: a systematic review and meta-analysis of randomized controlled trials.Statistical analysis plan for the 'Efficacy of Nitric Oxide in Stroke' (ENOS) trial.Speeding stroke recovery? A systematic review of amphetamine after stroke.Efficacy of nitric oxide, with or without continuing antihypertensive treatment, for management of high blood pressure in acute stroke (ENOS): a partial-factorial randomised controlled trial.Granulocyte-Colony Stimulating Factor (G-CSF) for stroke: an individual patient data meta-analysis.Continuing or Temporarily Stopping Prestroke Antihypertensive Medication in Acute Stroke: An Individual Patient Data Meta-Analysis.ESCAPS study protocol: a feasibility randomised controlled trial of 'Early electrical stimulation to the wrist extensors and wrist flexors to prevent the post-stroke complications of pain and contractures in the paretic arm'.Continuing versus Stopping Prestroke Antihypertensive Therapy in Acute Intracerebral Hemorrhage: A Subgroup Analysis of the Efficacy of Nitric Oxide in Stroke Trial.Effect of Treatment Delay, Stroke Type, and Thrombolysis on the Effect of Glyceryl Trinitrate, a Nitric Oxide Donor, on Outcome after Acute Stroke: A Systematic Review and Meta-Analysis of Individual Patient from Randomised Trials.Safety of carotid endarterectomy following thrombolysis for acute ischemic stroke.Route of Feeding as a Proxy for Dysphagia After Stroke and the Effect of Transdermal Glyceryl Trinitrate: Data from the Efficacy of Nitric Oxide in Stroke Randomised Controlled Trial.Glyceryl Trinitrate for Acute Intracerebral Hemorrhage: Results From the Efficacy of Nitric Oxide in Stroke (ENOS) Trial, a Subgroup Analysis.Incidence of First Stroke in Pregnant and Nonpregnant Women of Childbearing Age: A Population-Based Cohort Study From EnglandEffect of Hyperacute Administration (Within 6 Hours) of Transdermal Glyceryl Trinitrate, a Nitric Oxide Donor, on Outcome After Stroke: Subgroup Analysis of the Efficacy of Nitric Oxide in Stroke (ENOS) Trial.Ambulance-delivered transdermal glyceryl trinitrate versus sham for ultra-acute stroke: Rationale, design and protocol for the Rapid Intervention with Glyceryl trinitrate in Hypertensive stroke Trial-2 (RIGHT-2) trial (ISRCTN26986053).Stroke in women - from evidence to inequalities.Hypercholesterolaemia and vascular dementia.The Insulin Resistance Intervention after Stroke trial: A perspective on future practice and research.Increasing value and reducing waste in stroke research.Cerebral misery perfusion due to carotid occlusive disease.Preventing cognitive decline and dementia from cerebral small vessel disease: The LACI-1 Trial. Protocol and statistical analysis plan of a phase IIa dose escalation trial testing tolerability, safety and effect on intermediary endpoints of isosorbiIntravenous tranexamic acid for hyperacute primary intracerebral hemorrhage: Protocol for a randomized, placebo-controlled trial.The Nottingham Fatigue after Stroke (NotFAST) study: factors associated with severity of fatigue in stroke patients without depression.
P50
Q21144269-02DEFA52-63F8-4F98-9141-7B780F2553CAQ24201855-485B395D-A406-40D9-AE92-A7930927951CQ24245166-A76DBD38-4495-4527-9DF1-8C156033D5E4Q28218406-5B25E1D2-C140-46E5-9A61-E65C97BB11ADQ28219299-63C375A7-4E42-42A7-B7E0-FDC91F3A2E5CQ28219416-DD104D27-9CB7-41CC-96AE-578AEF3D5F96Q28222272-59E86284-54CF-414D-9AAC-D71E6B168061Q28222335-675A94C5-9D88-4417-8519-7268BEDAC096Q28973586-5CA8C845-A13A-4906-8FF6-7DCDD363CABBQ30490373-2BB0A636-24F1-4B4E-98BC-9996C8C743D5Q30617247-8D9434E2-8705-42D5-9A13-876510B6020AQ30682304-469417EB-BB72-4267-84F7-A65B5D079738Q30832922-7418C01B-875A-40E7-8372-3981F1B9D6D7Q30883837-A2BE8120-7A8E-456F-90F6-FE59E9A6EFD6Q33300843-149C9E76-8357-4E28-B339-B4E892F2D015Q33775718-93F39D92-9D68-41BF-9D28-1698EA9E3F24Q33841576-8EA12CB5-2831-479A-BD79-4AFEFE8612E1Q34239625-513015E3-FD1B-40B6-8E72-CEC6094C8EC5Q34531759-19D0BEAB-C48C-4DF3-ACBA-9C50819B5144Q34982137-7D841818-6B49-4787-A36B-BC2CFE7BCE6AQ35129507-197A1C47-CCAA-4EEB-A42B-C2C1CAB881EDQ36192434-02C8961B-A23E-4108-A3DB-C6E9B87A49E0Q36298885-70D72E5F-46B2-4C04-848C-B58532686391Q36472083-8B4D35DF-202C-403E-ABA4-41D26ED3E3F6Q36852813-D96AF1F8-0E01-4372-976B-5244A06792EDQ36854734-79A90E85-DD99-403F-A4E1-18A409EFBA11Q38125013-92262DD9-A471-45E5-A5F0-37DCF2E5BB85Q38372797-114991B7-FADC-4275-9385-07A47B0DE754Q38398672-AA6D9682-8DE2-400D-807C-195BD7F426C7Q38401442-EE118C9F-EEE6-4C73-B1F2-72A9FA06A89FQ38402029-8DFB4981-CE88-47FF-9FE6-51EAF04004BBQ38649591-9092CA09-9F8C-4F86-91FE-5EF8192235B1Q38653864-9BF48DD1-222D-44EF-A33B-98990BA5873BQ38664273-26E87D2C-02F1-4384-BD6D-B52AE7F972E7Q38842647-F4BC73B1-21D3-44EC-8EB0-490E436CE5F9Q39246077-1D13B1CF-1303-4BA4-8756-F88898B54238Q41678517-992FE3EA-0ED6-434F-997D-AAC0AEECEB1EQ42690507-271937B3-D16E-4A60-A854-AB5454B69F3CQ47443820-FC452986-46B9-4DDB-AA23-9877B6A204F1Q47682802-996F9F72-FDE5-4B06-B92E-6B627E691253
P50
description
researcher ORCID ID = 0000-0002-5871-8168
@en
wetenschapper
@nl
name
Nikola Sprigg
@ast
Nikola Sprigg
@en
Nikola Sprigg
@es
Nikola Sprigg
@nl
type
label
Nikola Sprigg
@ast
Nikola Sprigg
@en
Nikola Sprigg
@es
Nikola Sprigg
@nl
prefLabel
Nikola Sprigg
@ast
Nikola Sprigg
@en
Nikola Sprigg
@es
Nikola Sprigg
@nl
P31
P496
0000-0002-5871-8168